Bill Clinton Questioned by House Committee About Jeffrey Epstein’s Death
The death of Jeffrey Epstein continues to draw intense public attention years after it occurred. As part of a broader congressional review tied to newly released investigative records, former U.S. president Bill Clinton was recently questioned under oath during a closed-door deposition before the House Oversight Committee in New York. Lawmakers are reviewing connections and past interactions involving Epstein as they analyze millions of newly disclosed documents related to the case.
The deposition follows the release of more than three million files by the United States Department of Justice on January 20. The documents are tied to investigations surrounding Epstein’s criminal activities and his network of contacts. Their publication triggered renewed scrutiny of prominent figures who had past associations with him. In response, several individuals have been called to testify as Congress examines the broader context surrounding Epstein’s activities and the handling of the investigations.
Clinton appeared before lawmakers for two days of questioning shortly after testimony from Hillary Clinton. According to prior statements from committee chairman James Comer, the committee expected cooperation from witnesses as part of the review. Comer had indicated earlier that contempt proceedings could be considered if requested testimony was refused, underscoring the seriousness with which lawmakers are approaching the inquiry.
During the deposition, one line of questioning focused directly on Epstein’s death. Epstein died in August 2019 while being held at the Metropolitan Correctional Center as he awaited trial on federal sex-trafficking charges. Authorities officially ruled the death a suicide, but the circumstances have continued to fuel speculation and debate. Lawmakers asked Clinton whether he personally believed Epstein had taken his own life.
Clinton’s adviser Cheryl Mills initially challenged the phrasing of the question, suggesting it asked Clinton to speculate about events beyond his knowledge. A committee member then clarified the inquiry, asking whether Clinton believed Epstein—described during the exchange as a “friend”—had shown signs of suicidal behavior. Mills disputed that characterization, stating the two men were not friends but had only been “friendly” acquaintances.
Clinton ultimately told lawmakers that he did not have a definitive answer regarding Epstein’s death. He stated that he did not know the medical findings in detail and acknowledged that his understanding remained uncertain. While he noted he had formed a personal conclusion about the situation, he emphasized that none of those present could claim absolute knowledge beyond the official determination. For now, the testimony remains part of an ongoing congressional review as investigators continue examining Epstein’s network, the investigations surrounding him, and the broader questions that still attract public attention.
